Views & Analysis | Perspectives on pharma industry issues

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

R&D

Alzheimer's research is moving toward more selective targets

As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.

Articles

Challenges and advances in biotech drug regulation

We speak with independent regulatory affairs consultant, Mark Richardson, to get an update on the biotech regulatory landscape and to find out what advances we can expect in the next decade or so. Ahead of the Biotechnology for the non biotechnologist event, we speak with independent regulatory...

Articles

mHealth Monthly Mashup: Release 14.0 – Mobile health road ma...

Last month we took an “mhealth reality check” and concluded that despite the apparent confusion and contradiction surrounding… This month’s mashup provides a step-by-step guide for success in mobile health…

Articles

Editor’s Voice: August – Pop open the champagne, it’s our 3r...

As our birthday week comes to a close, Hannah Blake ponders on the hard work put into pharmaphorum over the past three years, and also in this month’s focus on rare diseases. When planning this piece, I tried to come up with various sayings and phrases with ‘three’ in. Plenty of nursery rhymes boast….

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Digital

Changing Faces: Digital and supplier hires, August 2026

Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access